Danish Healthtech Stock News

FLSmidth (CPSE:FLS) has completed its shift into a pure-play mining technology provider following the divestment of its cement business. The company has appointed Toni Laaksonen as CEO and announced a reshaped Board, including a new proposed Chair and several departures. New executives have been named to lead key mining business lines, signaling an organizational reset around the mining portfolio. FLSmidth now trades as a focused mining technology and services company, with its...

Methanex, Ørsted and Exolum have launched the U.K.’s first commercially ready biomethanol storage and marine bunkering service at the Port of Immingham, providing low‑carbon fuel for shipping and supporting Ørsted’s North Sea offshore wind maintenance vessels. The project shows how existing fuel infrastructure can be re‑tooled for green fuels, offering a practical pathway to cut domestic shipping emissions that currently exceed those from buses, trains and domestic aviation combined in the...

GN Store Nord (CPSE:GN) shares have been reacting to the company’s full year 2025 earnings, in which both sales and net income were lower than the prior year. This has put renewed attention on the stock’s recent performance. See our latest analysis for GN Store Nord. The full year 2025 earnings release appears to have been a key catalyst for the share price, with the stock posting a 1 day share price return of 1.05% and a 7 day share price return of 1.45% after a softer 30 day share price...

Genmab (CPSE:GMAB) has wrapped up FY 2025 with fourth quarter revenue of US$1.1b and basic EPS of US$0.50, rounding out a trailing twelve month EPS of US$15.5 on revenue of US$3.7b. The company has seen quarterly revenue move from US$715 million in Q1 2025 to US$1.1b in Q4, alongside EPS ranging from US$3.06 in Q1 to US$6.51 in Q3 and US$0.50 in Q4. This sets up a results season where investors are likely to focus on how these shifts flow through to margins and the durability of its earnings...

Ørsted A/S' ( CPH:ORSTED ) robust earnings report didn't manage to move the market for its stock. We did some digging...

H. Lundbeck (CPSE:HLUN B) is back in focus after reporting positive phase IIb data from the PROCEED trial of bocunebart, a potential migraine preventive therapy targeting patients with prior treatment failures. See our latest analysis for H. Lundbeck. The positive PROCEED data has come just days after Lundbeck reported full year 2025 results and proposed a higher dividend, and the stock has reacted with a 1 day share price return of 2.97% and 7 day share price return of 4.42%. That said, the...

Aktieselskabet Schouw & Co. (CPSE:SCHO) shareholders approved the release of BioMar as an Original Guarantor under the company’s bond terms. The decision removes BioMar from its status as a Material Subsidiary in the bond documentation. The approval was granted by a majority vote of shareholders. Aktieselskabet Schouw & Co. (CPSE:SCHO) is a Danish industrial group with holdings across several sectors, and BioMar has been one of its key subsidiaries. The shareholder-backed decision to remove...

Most readers would already know that TORM's (CPH:TRMD A) stock increased by 9.3% over the past three months. Given that...

The market shrugged off Novo Nordisk A/S' ( CPH:NOVO B ) solid earnings report. We did some digging and believe...

Key Insights Zealand Pharma's significant retail investors ownership suggests that the key decisions are influenced by...

DSV A/S' ( CPH:DSV ) recent soft profit numbers didn't appear to worry shareholders, as the stock price showed...

The market was pleased with the recent earnings report from Carlsberg A/S ( CPH:CARL B ), despite the profit numbers...

Pandora’s higher dividend proposal and steady EPS catch investors’ attention Pandora (CPSE:PNDORA) shares have been in focus after the jewellery group paired its 2025 earnings report with a higher proposed dividend and solid basic and diluted earnings per share figures. See our latest analysis for Pandora. Despite the upbeat 2025 earnings and higher proposed dividend, Pandora’s recent share price performance has been weak, with a 90 day share price return of 30.55% decline and a 1 year total...

As European markets remain buoyant, with the STOXX Europe 600 Index reaching new highs and optimism about the eurozone economy prevailing, investors are keenly observing potential opportunities amid recent market volatility. In this context, identifying stocks that may be undervalued relative to their intrinsic worth can be a strategic approach for those looking to capitalize on market conditions where cyclical and value-oriented segments are gaining traction.

As the pan-European STOXX Europe 600 Index reaches new highs, optimism about the eurozone economy is helping to counterbalance recent market volatility. With inflation slowing faster than forecast and key interest rates remaining steady, investors are increasingly focusing on small-cap stocks that may offer unique opportunities in this evolving landscape. Identifying promising stocks often involves looking for companies with strong fundamentals and potential growth catalysts that align well...

FLSmidth & Co. A/S ( CPH:FLS ) shareholders have had their patience rewarded with a 25% share price jump in the last...

Danske Bank A/S' ( CPH:DANSKE ) dividend will be increasing from last year's payment of the same period to DKK22.72 on...

It's been a mediocre week for Vestas Wind Systems A/S ( CPH:VWS ) shareholders, with the stock dropping 15% to kr.165...

Pandora A/S ( CPH:PNDORA ) has announced that it will be increasing its dividend from last year's comparable payment on...

Coloplast Q1 2026 Earnings Snapshot Coloplast (CPSE:COLO B) opened its 2026 financial year with Q1 revenue of DKK 7.0b and basic EPS of DKK 6.21, alongside trailing twelve month EPS of DKK 17.70 and net income of DKK 4.0b. Over recent quarters the company has seen quarterly revenue move in a tight band between DKK 6.9b and DKK 7.0b, while quarterly EPS has ranged from DKK 3.57 to DKK 6.21 as net income shifted between DKK 805m and DKK 1.40b. This sets up this report as a check-in on how much...

The board of Novo Nordisk A/S ( CPH:NOVO B ) has announced that it will be paying its dividend of DKK7.95 on the 31st...

The ChemoMetec A/S ( CPH:CHEMM ) share price has fared very poorly over the last month, falling by a substantial 40...

It's been a good week for Danske Bank A/S ( CPH:DANSKE ) shareholders, because the company has just released its latest...

There's been a notable change in appetite for GN Store Nord A/S ( CPH:GN ) shares in the week since its yearly report...